Insiders who reported open-market trades in the last 12 months at the companies Joseph Burnett files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Matthew B. Klein - $185K in CLPT purchases and sales in the last 12 months
Timothy T. Richards - $66K in CLPT purchases and sales in the last 12 months
Lynnette C. Fallon - $57K in CLPT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Joseph Burnett is a corporate insider, tracked as CEO and President, Director of ClearPoint Neuro, Inc. (CLPT). InsiderAlpha holds 17 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Joseph Burnett submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Joseph Burnett been buying or selling stock?
Recorded transactions: 0 open-market purchases and 11 open-market sales ($3.16M) across all tracked filings.
Joseph Burnett is CEO and President, Director of ClearPoint Neuro, Inc. (CLPT). 17 SEC Form 4 filings on record going back to 2025, most recently on 3 September 2026. Most recent open-market trade: sold $388K of CLPT on 1 July 2026. Lifetime open-market sales: $3.16M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Joseph Burnett.
InsiderAlpha's records for Joseph Burnett go back to 2025: 17 primary Form 4 filings, an average of 8.5 per year. 16 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
